Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma

Yongshun Zheng,Ran Jia,Jun Li,Xiaohe Tian,Yeben Qian
DOI: https://doi.org/10.1186/s12951-022-01554-y
IF: 10.2
2022-07-21
Journal of Nanobiotechnology
Abstract:Currently, systemic therapies for patients with advanced-stage hepatocellular carcinoma (HCC) rely mainly on systemic drugs. However, traditional systemic drugs have a high rate of serious adverse events, and the curative effects of some potential anticancer drugs, such as curcumin (CUR) and resveratrol (RSV), are less apparent due to their poor bioavailability. Therefore, it is urgent to develop a highly effective therapy to improve patient prognosis. Herein, an injectable HCC-targeted nanoparticle (NP) was designed to deliver CUR and RSV to hepatoma cells.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?